Business Description
Pharmosa Biopharm Inc
ISIN : TW0006875008
Total Employee Number:
31Description
Pharmosa Biopharm Inc is a world-class biotechnology company. The Company's principal business activities comprise the development and commercialization of inventive biopharmaceutical drugs. Its product portfolio includes sustained-release dosage forms and drug-device combination products intended for home based therapies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 11.36 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.28 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 14.92 | |||||
Beneish M-Score | -1.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | -3.2 | |||||
3-Year FCF Growth Rate | -11.5 | |||||
3-Year Book Growth Rate | 21.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 17.72 | |||||
9-Day RSI | 32.18 | |||||
14-Day RSI | 39.93 | |||||
3-1 Month Momentum % | -6.69 | |||||
6-1 Month Momentum % | -30.85 | |||||
12-1 Month Momentum % | -11.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 12.11 | |||||
Quick Ratio | 11.91 | |||||
Cash Ratio | 11.37 | |||||
Days Inventory | 199.97 | |||||
Days Sales Outstanding | 18.09 | |||||
Days Payable | 12.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | 0.36 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.38 | |||||
Operating Margin % | -598.88 | |||||
Net Margin % | -570.63 | |||||
EBITDA Margin % | -520.7 | |||||
FCF Margin % | -708.85 | |||||
OCF Margin % | -531.43 | |||||
ROE % | -22.01 | |||||
ROA % | -19.68 | |||||
ROIC % | -71.49 | |||||
3-Year ROIIC % | -30.08 | |||||
ROC (Joel Greenblatt) % | -98.06 | |||||
ROCE % | -20.7 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 68.11 | |||||
PB Ratio | 2.94 | |||||
Price-to-Tangible-Book | 2.95 | |||||
EV-to-EBIT | -9.33 | |||||
EV-to-EBITDA | -10.16 | |||||
EV-to-Revenue | 52.94 | |||||
EV-to-FCF | -7.93 | |||||
| Price-to-Net-Current-Asset-Value | 4.53 | |||||
| Price-to-Net-Cash | 4.88 | |||||
Earnings Yield (Greenblatt) % | -10.72 | |||||
FCF Yield % | -10.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmosa Biopharm Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 67.268 | ||
| EPS (TTM) (NT$) | -2.98 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.79 | ||
| 3-Year Sortino Ratio | -1.01 | ||
| Volatility % | 40.94 | ||
| 14-Day RSI | 39.93 | ||
| 14-Day ATR (NT$) | 1.376696 | ||
| 20-Day SMA (NT$) | 37.2825 | ||
| 12-1 Month Momentum % | -11.99 | ||
| 52-Week Range (NT$) | 33.6 - 65 | ||
| Shares Outstanding (Mil) | 129.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmosa Biopharm Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmosa Biopharm Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmosa Biopharm Inc Frequently Asked Questions
What is Pharmosa Biopharm Inc(ROCO:6875)'s stock price today?
The current price of ROCO:6875 is NT$35.55. The 52 week high of ROCO:6875 is NT$65.00 and 52 week low is NT$33.60.
When is next earnings date of Pharmosa Biopharm Inc(ROCO:6875)?
The next earnings date of Pharmosa Biopharm Inc(ROCO:6875) is .
Does Pharmosa Biopharm Inc(ROCO:6875) pay dividends? If so, how much?
Pharmosa Biopharm Inc(ROCO:6875) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pharmosa Biopharm Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers